#BIOTech hashtag - Bluesky

AnaptysBio Director Schmid Sells $1.16M in ANAB Stock Director Thomas Schmid sold $1.16M of ANAB stock on Apr 1–2, 2026 (Investing.com/SEC Form 4). Institutional investors should verify 10b5-1 coverage and watch for clustered insider activity.

4 hours ago

AnaptysBio Director Schmid Sells $1.16M in ANAB Stock: Director Thomas Schmid sold $1.16M of ANAB stock on Apr 1–2, 2026 (Investing.com/SEC Form 4). Institutional investors should verify 10b5-1 coverage and watch for… 👈 Read full analysis #AnaptysBio #StockMarket #Investing #InsiderTrading #Biotech

0 0 0 0

Neumora Therapeutics 13D/A Filed on Apr 1 Form 13D/A filed Apr 1, 2026; 5% SEC disclosure threshold and 10-day amendment rule cited. Neumora's governance trajectory could alter R&D prioritization and partner options.

5 hours ago

Neumora Therapeutics 13D/A Filed on Apr 1: Form 13D/A filed Apr 1, 2026; 5% SEC disclosure threshold and 10-day amendment rule cited. Neumora's governance trajectory could alter R&D prioritization and partner options. 👈 Read full analysis #NeumoraTherapeutics #SECfiling #13DA #biotech #investing

0 0 0 0

Capricor Therapeutics Director Sells $3.5m in Shares Capricor director divested $3.5m of CAPR stock (Form 4 filed Apr 1, 2026; Investing.com Apr 2, 2026). Fazen analysis shows a 15% YoY rise in small‑cap biotech insider sell‑value in Q1 2026.

5 hours ago

Capricor Therapeutics Director Sells $3.5m in Shares: Capricor director divested $3.5m of CAPR stock (Form 4 filed Apr 1, 2026; Investing.com Apr 2, 2026). Fazen analysis shows a 15% YoY rise in small‑cap… 👈 Read full analysis #CapricorTherapeutics #Biotech #InsiderSelling #StockMarket #Investing

0 0 0 0

Beam Therapeutics CEO Evans Sells $1.1m Stock Beam Therapeutics CEO Evans sold $1.1m of stock (SEC Form 4 filed Apr 1, 2026), a disclosure event that is small relative to typical biotech market caps and requires contextual analysis.

6 hours ago

Beam Therapeutics CEO Evans Sells $1.1m Stock: Beam Therapeutics CEO Evans sold $1.1m of stock (SEC Form 4 filed Apr 1, 2026), a disclosure event that is small relative to typical biotech market caps and requires… 👈 Read full analysis #BeamTherapeutics #Biotech #StockMarket #Investing #SECFilings

0 0 0 0

@j-e-landau.bsky.social

8 hours ago

The Dream of Mass-Produced People I recently heard about a tech startup called R3 Bio, which intends to produce literally brainless human clones of wealthy clients, which can be harvested for organs or used for full-body transplant…

New Blog Post: The Dream of Mass-Produced People
jelandau.com/2026/04/01/t...
#scifi #cloning #biotech #robotics

0 0 0 0

FinAnxiety

@finanxiety.bsky.social

8 hours ago

Article image

Novo Nordisk weighs in on Lilly's FDA-approved weight-loss pill. A strong signal for the biotech sector! But with Lilly entering the market, could there be competitive impacts? Eyes on $NVO and $LLY. #pharma #biotech #BreakingBroke

0 0 1 0

FinAnsia

@finansia.bsky.social

8 hours ago

Article image

Novo Nordisk commenta l'approvazione FDA della pillola dimagrante di Lilly. Un segnale forte per il settore biotech! Ma con Lilly che entra nel mercato, ci saranno ripercussioni competitive? Occhi puntati su $NVO e $LLY. #pharma #biotech #AllInSullaPaura

0 0 1 0

@pharmalot.bsky.social

9 hours ago

Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest The FDA has often failed to share information on how it determines whether advisory committee members have financial conflicts of interest, according to a new review.

Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest.. statnews.com/pharmalot/20... #pharma #biotech #FDA #conflicts #conflictsofinterest

0 0 0 0

Bizniz Insider PH

@biznizinsiderph.bsky.social

10 hours ago

Why the Insilico Medicine and Lilly Deal Is One of the Most Significant Moments in Pharmaceutical History - AktieGo Insilico Medicine and Eli Lilly have signed a $2.75 billion AI drug discovery deal. Here's what it means for pharmaceutical R&D and the future of medicine.

Historic moment in pharma:
Lilly inks up to $2.75B deal with Insilico for generative AI drug discovery.
$115M upfront + milestones for novel oral therapeutics in multiple high-value areas.
AI-designed drugs just got Big Pharma’s strongest validation.
#AIinPharma #Biotech
aktiego.com/sectors/biot...

0 0 0 0

Chris J Fisher

@c-j-fisher.bsky.social

11 hours ago

It's always great to get some face time in with fellow #Biotech and #LifeScience communications pros.

It can be hard to squeeze in-person events into busy schedules.

But it does pay off in spades to catch up, talk shop, and share common struggles without a screen in between.

(5/6) 🧪

4 1 1 0

Aircraft above Arth, SZ 🚁🛩️

@abovearth.bsky.social

14 hours ago

PlaneAlert ICAO: A70E5B Tail: N554AV
Owner: AbbVie
Aircraft: Gulfstream G600
2026-04-01 18:03:26 CEST
GA6C Bizjet Biotech Pharmaceuticals
adsb planefence planealert by kx1t - wiki - adsbexchange - planefence

0 0 0 0

e184

@e184media.bsky.social

15 hours ago

The Age of High-Throughput Screening Scientists don’t have to do experiments one by one anymore

High-throughput screening has sped up progress in the life sciences enormously. Now, it's getting even faster. #biotech
open.substack.com/pub/e184/p/t...

0 0 0 0

robot2trade

@robot2trade.bsky.social

16 hours ago

BIOTECH EXPLOSION: $CYCN +430% 🧬💥

The absolute definition of "Unusual Activity!" $CYCN is vertical today after announcing a transformational merger with Korsana Biosciences

@Cyclerion @ReginaGraul @JPMorgan @Venrock #CYCN #KRSA #Biotech #PennyStocks #Merger #AlzheimersResearch

0 0 0 0

@icgebofficial.bsky.social

17 hours ago

Longevity biotech investment in 2026 is no longer a guessing game – the DLT Chatbot puts hard numbers around where capital is flowing.

Link as first comment.

#longevity #biotech #investment #innovation

0 0 1 0

icgeb.org

18 hours ago

🚨 The ICGEB March 2026 Newsletter is out now! Discover the latest updates on global research, partnerships, events, and scientific breakthroughs across our international network 🌍🔬 Read it here 👉 https://9ljio.r.a.d.sendibm1.com/mk/mr/sh/1t6AVsd2XFnIG8UXLMYlmltN2FcBYD/xO35dWn2De8U #ICGEB #Science #Research #Biotech #GlobalScience

🚨 The ICGEB March 2026 Newsletter is out now!

Discover the latest updates on global research, partnerships, events, and scientific breakthroughs across our international network 🌍🔬

Read it here 👉 9ljio.r.a.d.sendibm1.com/mk/mr/sh/1t6...

#ICGEB #Science #Research #Biotech #GlobalScience

0 0 0 0

PeptiMatrix

@peptimatrix.bsky.social

19 hours ago

As the UK moves toward phasing out animal testing, scientists need ethical, scalable alternatives.

Animal-free hydrogels deliver:
- Reproducibility
- Ethical research
- Better control
- Faster innovation

Time to rethink research tools.

www.peptimatrix.com

#Biotech #LifeSciences #EthicalScience

0 0 0 0

19 hours ago

At AMWC Monaco, Allergan Aesthetics says the future of facial aging is less about looking ‘done’ and more about looking well.

Link as first comment.

#longevity #aesthetics #innovation #biotech

0 0 1 0

@drtimos.bsky.social

20 hours ago

LucidQuest

Accelerate success in #Pharma & #Biotech!

🔬 Join LucidQuest on YouTube for #insights across therapeutic areas, as well as #ArtificialIntelligence, #MachineLearning, #DigitalHealth & more.

Subscribe & shape the future of #healthcare: http://dlvr.it/TRpmgM 🚀

#Strategy

1 0 0 0

22 hours ago

Researchers use AI to redesign antibody fragments that work inside human cells, opening a new angle on Alzheimer’s and neurodegeneration.

Link as first comment.

#longevity #geroscience #alzheimers #neurodegeneration #biotech

@universityofessex.bsky.social

2 1 2 0